Skip to content
Mats Palmquist appointed CEO of Orkla Health Holding

Press release -

Mats Palmquist appointed CEO of Orkla Health Holding

The Board of Directors of Orkla Health Holding has appointed Mats Palmquist as the new Chief Executive Officer. Mats Palmquist will succeed Orkla Health Holding’s CFO and interim CEO, Christian Rykke, and is expected to assume the position after the summer 2025.

Mats Palmquist brings over two decades of international leadership experience across both B2C and B2B sectors. He has extensive expertise in the entire value chain – from sales & marketing, mergers & acquisitions to supply chain and manufacturing operations.

Mats Palmquist joins Orkla Health from Convini, where he has served as CEO since 2018. Convini is a Sweden-based foodtech company offering self-service food solutions to workplaces. During his tenure, Convini achieved strong growth through both organic and inorganic initiatives.

Prior to Convini, Mats Palmquist held various leadership roles at Oriflame Cosmetics over a 14-year period. He successfully scaled the company’s presence in Eastern and Central Europe.

Palmquist holds a master’s degree in civil engineering from Chalmers University of Technology in Sweden.

Tomas Settevik, Chairman of the Board of Directors at Orkla Health Holding:

“We are very pleased that Mats Palmquist has accepted the role as CEO of Orkla Health Holding. His extensive international experience and proven track record in driving growth make him highly relevant for the journey ahead. Mats’s drive and expertise will be a strong and valuable contribution to Orkla Health’s future.”

Incoming CEO Mats Palmquist added:

“I’m honored to join Orkla Health Holding at such an exciting time. I look forward to working with the talented teams behind the company’s strong brands and to shaping the next growth chapter together – building on the great achievements already in place.”

Mats Palmquist will begin his onboarding during the coming months.

About Orkla Health Holding
Orkla Health Holding is one of Europe’s leading branded consumer health companies. With a broad portfolio of science-backed products spanning from supplements to wound care, oral care, and healthcare solutions, our almost 2,000 employees serve consumers in more than 60 markets through a multi-channel setup.

Our well-known brands include Möller’s, Jordan, VitaePro, Oslo Skin Lab, Cederroth First Aid, Salvequick, Livol, Maxim, and Sana-Sol – trusted names that reflect our commitment to inspiring people to live healthier lives.

With more than 150 years of heritage, Orkla Health Holding combines deep consumer insight with innovation and scientific expertise to deliver high-quality health solutions tailored to local needs.

Orkla Health Holding is headquartered in Norway and is owned by the industrial investment company Orkla ASA.
Learn more at www.orklahealth.com.

Topics

Categories


Orkla ASA is a leading industrial investment company. Its scope of activity is brands and consumer-oriented companies. At present, Orkla has 10 portfolio companies.

Orkla has a long-term, industrial approach to its portfolio companies. We invest in companies where we can contribute to further value creation through our industry expertise, consumer insight and experience in building leading brands.

Orkla ASA is listed on the Oslo Stock Exchange.

Contacts

Nilüfer Sahin

Interim Communications Manager +4526822297
Media Content Panel
Bilde1.jpg
Bilde1.jpg
License:
Media Use
File format:
.jpg
Size:
986 x 708, 149 KB
Download

Welcome to Orkla Global!

Orkla ASA is a leading industrial investment company. Its scope of activity is brands and consumer-oriented companies. At present, Orkla has 10 portfolio companies.

Orkla has a long-term, industrial approach to its portfolio companies. We invest in companies where we can contribute to further value creation through our industry expertise, consumer insight and experience in building leading brands.

Orkla ASA is listed on the Oslo Stock Exchange.

Orkla Global